Homologous recombination deficiency (HRD) and genomic associations in non-small cell lung cancer (NSCLC) using a novel HRD signature (HRDsig)

This abstract was presented at the 2022 European Society for Medical Oncology Congress. View the full abstract on esmo.org.

September 7, 2022